Log in

ASX:MVPMedical Developments International Stock Price, Forecast & News

A$7.63
+0.06 (+0.79 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$7.17
Now: A$7.63
A$7.66
50-Day Range
A$7.63
MA: A$7.63
A$7.63
52-Week Range
A$3.76
Now: A$7.63
A$11.78
Volume169,499 shs
Average VolumeN/A
Market Capitalization$500.58 million
P/E Ratio448.82
Dividend Yield0.57%
BetaN/A
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. Medical Developments International Limited is headquartered in Scoresby, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9547 1888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.25 million
Cash FlowA$0.36 per share
Book ValueA$0.69 per share

Profitability

Miscellaneous

Employees55
Market Cap$500.58 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MVP News and Ratings via Email

Sign-up to receive the latest news and ratings for MVP and its competitors with MarketBeat's FREE daily newsletter.

Medical Developments International (ASX:MVP) Frequently Asked Questions

How has Medical Developments International's stock been impacted by COVID-19 (Coronavirus)?

Medical Developments International's stock was trading at A$6.48 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MVP shares have increased by 17.7% and is now trading at A$7.63. View which stocks have been most impacted by Coronavirus.

How often does Medical Developments International pay dividends? What is the dividend yield for Medical Developments International?

Medical Developments International declared a Interim dividend on Thursday, February 20th. Stockholders of record on Friday, April 17th will be given a dividend of 0.02 per share on Friday, April 17th. This represents a dividend yield of 0.18%. The ex-dividend date is Thursday, March 5th. View Medical Developments International's dividend history.

Has Medical Developments International been receiving favorable news coverage?

News articles about MVP stock have been trending negative on Sunday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Developments International earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news about Medical Developments International.

Who are some of Medical Developments International's key competitors?

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Petroleum (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Global (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB).

Who are Medical Developments International's key executives?

Medical Developments International's management team includes the following people:
  • Mr. John Stewart Sharman, Chief Exec. Officer (Age 53)
  • Mr. Mark Edwards, CFO & Company Sec.
  • Dr. Scott Courtney, Director of Research & Operations
  • Michelle Bradney, Head of Medical Affairs
  • Wai Ng Chi, Head of Regulatory Affairs

What is Medical Developments International's stock symbol?

Medical Developments International trades on the ASX under the ticker symbol "MVP."

What is Medical Developments International's stock price today?

One share of MVP stock can currently be purchased for approximately A$7.63.

How big of a company is Medical Developments International?

Medical Developments International has a market capitalization of $500.58 million and generates $22.25 million in revenue each year. Medical Developments International employs 55 workers across the globe.

What is Medical Developments International's official website?

The official website for Medical Developments International is www.medicaldev.com.

How can I contact Medical Developments International?

The company can be reached via phone at 61 3 9547 1888.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.